Evidence mapPaperPMID 38569737Full record

ArticleBMJ case reports2024

Acute quadruple extremity compartment syndrome due to angio-oedema after polypharmacy overdose including olmesartan medoxomil, telmisartan and vildagliptin.

Yumi Kono, Kohei Takimoto, Motoki Fujii, Yoshiro Hayashi

Abstract readCase Reports
In one paragraph

Article in BMJ case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yumi KonoDepartment of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan.
Kohei TakimotoDepartment of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan mm7706tk@gmail.com.ORCID http://orcid.org/0000-0001-9520-8530
Motoki FujiiDepartment of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan.
Yoshiro HayashiDepartment of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan.
Kameda Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report describes a rare manifestation of acute compartment syndrome (ACS) involving all four extremities, precipitated by angio-oedema in a middle-aged woman who consumed an overdose of multiple medications: nifedipine, azelnidipine, amlodipine besylate, olmesartan medoxomil, telmisartan, esaxerenone and vildagliptin. She presented with haemodynamic instability, necessitating intubation. Despite stabilising haemodynamic parameters within 24 hours, she manifested escalating extremity oedema. At 52 hours after ingestion, mottled skin was observed, along with necrotic alterations in the swollen hands and compartment pressures exceeding 30 mm Hg in all extremities. ACS was diagnosed, leading to fasciotomies. The aetiology is postulated to be drug-induced angio-oedema, possibly intensified by the concurrent overdose of olmesartan medoxomil, telmisartan and vildagliptin, each of which has a risk of angio-oedema even at standard dosages. This scenario is a very rare case caused by drug-induced angio-oedema, which underscores the importance of vigilant monitoring to detect ACS in patients with progressing limb oedema.

Indexed as

AngioedemaDrug OverdoseHypertensionAmlodipineAntihypertensive AgentsFemaleHumansMiddle AgedOlmesartan MedoxomilPolypharmacyTelmisartanTetrazolesVildagliptinAmlodipineAntihypertensive AgentsOlmesartan MedoxomilTelmisartanTetrazolesVildagliptinAdult intensive careDrug interactionsDrugs misuse (including addiction)Orthopaedic and trauma surgery

Identifiers

PMID38569737
PMCPMC10989128
OpenAlexW4393865961

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.